# Escalating Monthly Doses of Tafenoquine in Healthy Volunteers

> **NCT05203744** · PHASE4 · UNKNOWN · sponsor: **Naval Medical Research Center** · enrollment: 200 (estimated)

## Conditions studied

- Prophylaxis

## Interventions

- **DRUG:** Tafenoquine prophylaxis

## Key facts

- **NCT ID:** NCT05203744
- **Lead sponsor:** Naval Medical Research Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-10
- **Primary completion:** 2022-12-03
- **Final completion:** 2022-12-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-04-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05203744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05203744, "Escalating Monthly Doses of Tafenoquine in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05203744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*